s6y ARGOS THERAPEUTICS INC 10-K

ARGOS THERAPEUTICS INC 10-K, filed Mar 31, 2015: IDEA: XBRL DOCUMENT

Note 3 - Fair Value of Financial Instruments
12 Months Ended
Dec. 31, 2014
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
3. Fair Value of Financial Instruments

The estimated fair values of all of the Company’s financial instruments, excluding long-term debt, approximate their carrying amounts in the Consolidated Balance Sheets as of December 31, 2013 and 2014.

As of December 31, 2013 and December 31, 2014, the Company held certain assets that are required to be measured at fair value on a recurring basis. These assets include money market funds included in cash equivalents and short-term investments in corporate debt securities. The valuation of these financial instruments uses a three tiered approach, which requires that fair value measurements be classified and disclosed in one of three tiers. These tiers are: Level 1, defined as quoted prices in active markets for identical assets or liabilities; Level 2, defined as valuations based on observable inputs other than those included in Level 1, such as quoted prices for similar assets and liabilities in active markets, or other inputs that are observable or can be corroborated by observable input data; and Level 3, defined as valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants.

The Company’s Level 1 assets consist of money-market funds and the method used to estimate the fair value of the Level 1 assets is based on observable market data as these money-market funds are publicly-traded. The Company’s Level 2 assets consist of short-term debt instruments in corporate debt securities valued using independent pricing services which normally derive security prices from recently reported trades for identical or similar securities, making adjustments based on significant observable transactions. As of each balance sheet date, observable market inputs may include trade information, broker or dealer quotes, bids, offers or a combination of these data sources.

 As of December 31, 2013 and December 31, 2014, these financial instruments and respective fair values have been classified as follows:

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Balance as of
December 31,
2013
Assets
Money-market funds
$
22,891,418
$
—
$
—
$
22,891,418
Corporate debt securities – short-term
—
13,659,812
—
13,659,812
Total assets at fair value
$
22,891,418
$
13,659,812
$
—
$
36,551,230

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Balance as of
December 31,
2014
Assets
Money-market funds
$
35,541,595
$
—
$
—
$
35,541,595
Corporate debt securities – short-term
—
20,266,243
—
20,266,243
Restricted cash – long-term
1,325,000
1,325,000
Total assets at fair value
$
36,866,595
$
20,266,243
$
—
$
57,132,838

During the years ended December 31, 2013 and 2014, there were no transfers between Levels 1 and 2 assets.

The changes in the balance of Level 3 liabilities for the year ended December 31, 2013 were as follows:

 
Fair Value Measurements Using Significant Unobservable
Inputs (Level 3)
 
 
Beginning
Balance
   
Net Change in
Unrealized
(Gains) Losses
   
Reduction
   
Ending
Balance
 
Warrant Liability
  $ 6,392,652     $ (355,352 )   $ (6,037,300 )   $ —  
  $ 6,392,652     $ (355,352 )   $ (6,037,300 )   $ —  

During the year ended December 31, 2013, all outstanding warrants to purchase preferred stock were cancelled. As a result, there were no warrants to purchase preferred stock outstanding as of December 31, 2013 or 2014, and there were no Level 3 assets or liabilities outstanding during the year ended December 31, 2014.

The fair value of the Company’s long-term debt was derived by evaluating the nature and terms of each note, considering the prevailing economic and market conditions as of each balance sheet date and based on the Level 2 valuation hierarchy of the fair value measurements standard using a present value methodology. The fair value of the Company’s long-term debt as of December 31, 2013 approximated its carrying value of $7.0 million. The fair value of the Company’s long-term debt as of December 31, 2014 was approximately $19.4 million compared with its carrying value of $19.8 million.